Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01.10.2012 | Article

Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit

verfasst von: S. Rödl, B. Resch, N. Hofer, I. Marschitz, G. Madler, E. Eber, G. Zobel

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

The objective of this investigation was to compare different scoring systems to assess the severity of illness in infants with bronchiolitis admitted to a tertiary paediatric intensive care unit (PICU). Over an 18-year period (1990–2007), infants with bronchiolitis aged up to 12 months and admitted to the PICU were prospectively scored using the Pediatric Risk of Mortality III (PRISM III) score, the Organ System Failure (OSF) score and the Acute Physiologic Score for Children (APSC) within 24 h. Infants were compared as to whether or not bronchiolitis was associated with respiratory syncytial virus (RSV). There was no difference between 113 RSV-positive and 80 RSV-negative infants regarding gestational age, birth weight, rate of premature delivery or bronchopulmonary dysplasia (BPD). The PRISM III score differed significantly between RSV-positive and RSV-negative cases (3.27 ± 0.39 vs. 1.96 ± 0.44, p = 0.006), as did the OSF score (0.56 ± 0.05 vs. 0.35 ± 0.06, p = 0.049) and the APSC (5.16 ± 0.46 vs. 4.1 ± 0.53, p = 0.048). All scores were significantly higher in the subgroup with mechanical ventilation (p < 0.0001). The mean time of ventilation was significantly higher in the RSV-positive group compared to the RSV-negative group (6.39 ± 1.74 days vs. 2.4 ± 0.47 days, p < 0.001). Infants suffering from RSV-positive bronchiolitis had higher clinical scores corresponding with the severity of bronchiolitis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef
2.
Zurück zum Zitat Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743–752PubMedCrossRef Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743–752PubMedCrossRef
3.
Zurück zum Zitat Pollack MM, Patel KM, Ruttimann UE (1997) The Pediatric Risk of Mortality III—Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 131:575–581PubMedCrossRef Pollack MM, Patel KM, Ruttimann UE (1997) The Pediatric Risk of Mortality III—Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 131:575–581PubMedCrossRef
4.
Zurück zum Zitat Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM (1987) Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111:324–328PubMedCrossRef Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM (1987) Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111:324–328PubMedCrossRef
5.
Zurück zum Zitat Zobel G, Kuttnig M, Grubbauer HM, Rödl S (1990) Evaluation of clinical scoring systems in critically ill infants and children. Clin Intensive Care 1:202–206PubMed Zobel G, Kuttnig M, Grubbauer HM, Rödl S (1990) Evaluation of clinical scoring systems in critically ill infants and children. Clin Intensive Care 1:202–206PubMed
6.
Zurück zum Zitat Zobel G, Kuttnig M, Ring E, Grubbauer HM (1990) Clinical scoring systems in children with continuous extracorporeal renal support. Child Nephrol Urol 10:14–17PubMed Zobel G, Kuttnig M, Ring E, Grubbauer HM (1990) Clinical scoring systems in children with continuous extracorporeal renal support. Child Nephrol Urol 10:14–17PubMed
7.
Zurück zum Zitat Zobel G, Rödl S, Rigler B, Metzler H, Dacar D, Grubbauer HM, Beitzke A (1993) Prospective evaluation of clinical scoring systems in infants and children with cardiopulmonary insufficiency after cardiac surgery. J Cardiovasc Surg (Torino) 34:333–337 Zobel G, Rödl S, Rigler B, Metzler H, Dacar D, Grubbauer HM, Beitzke A (1993) Prospective evaluation of clinical scoring systems in infants and children with cardiopulmonary insufficiency after cardiac surgery. J Cardiovasc Surg (Torino) 34:333–337
8.
Zurück zum Zitat van Keulen JG, Polderman KH, Gemke RJBJ (2005) Reliability of PRISM and PIM scores in paediatric intensive care. Arch Dis Child 90:211–214PubMedCrossRef van Keulen JG, Polderman KH, Gemke RJBJ (2005) Reliability of PRISM and PIM scores in paediatric intensive care. Arch Dis Child 90:211–214PubMedCrossRef
9.
Zurück zum Zitat van Keulen JG, Gemke RJBJ, Polderman KH (2005) Effect of training and strict guidelines on the reliability of risk adjustment systems in paediatric intensive care. Intensive Care Med 31:1229–1234PubMedCrossRef van Keulen JG, Gemke RJBJ, Polderman KH (2005) Effect of training and strict guidelines on the reliability of risk adjustment systems in paediatric intensive care. Intensive Care Med 31:1229–1234PubMedCrossRef
10.
11.
Zurück zum Zitat Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, Hemming G (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530PubMedCrossRef Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, Hemming G (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530PubMedCrossRef
12.
Zurück zum Zitat Resch B, Gusenleitner W, Müller W (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30:193–197PubMedCrossRef Resch B, Gusenleitner W, Müller W (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30:193–197PubMedCrossRef
13.
Zurück zum Zitat Resch B, Gusenleitner W, Müller W, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol Infect Dis 25:120–122PubMedCrossRef Resch B, Gusenleitner W, Müller W, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol Infect Dis 25:120–122PubMedCrossRef
14.
Zurück zum Zitat Welliver RC (2009) Bronchiolitis and infectious asthma. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Feigin and Cherry’s textbook of pediatric infectious diseases, 6th edn. Saunders Elsevier, Philadelphia, pp 277–287 Welliver RC (2009) Bronchiolitis and infectious asthma. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Feigin and Cherry’s textbook of pediatric infectious diseases, 6th edn. Saunders Elsevier, Philadelphia, pp 277–287
15.
Zurück zum Zitat Resch B, Gusenleitner W, Mueller WD (2007) Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr 96:495–498PubMedCrossRef Resch B, Gusenleitner W, Mueller WD (2007) Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr 96:495–498PubMedCrossRef
16.
Zurück zum Zitat Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192–197PubMedCrossRef Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192–197PubMedCrossRef
17.
Zurück zum Zitat Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278–285PubMed Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278–285PubMed
18.
Zurück zum Zitat Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C (2010) Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 95:35–41PubMedCrossRef Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C (2010) Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 95:35–41PubMedCrossRef
19.
Zurück zum Zitat Tasker RC, Roe MFE, Bloxham DM, White DK, Ross-Russell RI, O’Donnell DR (2004) The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med 30:2257–2262PubMedCrossRef Tasker RC, Roe MFE, Bloxham DM, White DK, Ross-Russell RI, O’Donnell DR (2004) The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med 30:2257–2262PubMedCrossRef
20.
Zurück zum Zitat Roe MFE, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O’Donnell DR (2004) Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137:139–145PubMedCrossRef Roe MFE, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O’Donnell DR (2004) Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137:139–145PubMedCrossRef
21.
Zurück zum Zitat Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115:e7–e14PubMed Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115:e7–e14PubMed
23.
Zurück zum Zitat Resch B, Gusenleitner W, Mandl C, Müller W (2000) Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 19:587–588PubMed Resch B, Gusenleitner W, Mandl C, Müller W (2000) Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 19:587–588PubMed
24.
Zurück zum Zitat Thorburn K (2009) Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94:99–103PubMedCrossRef Thorburn K (2009) Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94:99–103PubMedCrossRef
Metadaten
Titel
Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit
verfasst von
S. Rödl
B. Resch
N. Hofer
I. Marschitz
G. Madler
E. Eber
G. Zobel
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1612-z

Weitere Artikel der Ausgabe 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.